Cholic acid increases plasma cholesterol in Smith-Lemli-Opitz syndrome: A pilot study
Authors:
Open Access
- 28 November 2023
- journal article
- research article
- Published by Elsevier in Molecular Genetics and Metabolism Reports
- Vol. 38, 101030
Abstract
No abstract availableKeywords
Funding Information
- Rare Diseases Clinical Research Network (1 U2C TR002818 01, R01HD092659)
- National Institutes of Health
- National Center for Advancing Translational Sciences
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
This publication has 30 references indexed in Scilit:
- 7-Dehydrocholesterol-derived oxysterols and retinal degeneration in a rat model of Smith–Lemli–Opitz syndromeBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012
- DHCEO accumulation is a critical mediator of pathophysiology in a Smith–Lemli–Opitz syndrome modelNeurobiology of Disease, 2012
- Novel oxysterols observed in tissues and fluids of AY9944-treated rats: a model for Smith-Lemli-Opitz syndromeJournal of Lipid Research, 2011
- Conversion of 7-Dehydrocholesterol to 7-Ketocholesterol Is Catalyzed by Human Cytochrome P450 7A1 and Occurs by Direct Oxidation without an Epoxide IntermediateJournal of Biological Chemistry, 2011
- Biological activities of 7-dehydrocholesterol-derived oxysterols: implications for Smith-Lemli-Opitz syndromeJournal of Lipid Research, 2010
- Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome: Thinking Beyond Cholesterol Deficiency2009
- Effects of Dietary Cholesterol and Simvastatin on Cholesterol Synthesis in Smith-Lemli-Opitz SyndromePediatric Research, 2009
- Balancing cholesterol synthesis and absorption in the gastrointestinal tractJournal of Clinical Lipidology, 2008
- Genetic regulation of cholesterol absorption and plasma plant sterol levelsJournal of Lipid Research, 2003
- Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndromeThe Lancet, 1993